PEDIATRICS Vol. 85 No. 2 February 1990, pp. 233-234
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FOST, N.
Right arrow Articles by SCHYDLOWER, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FOST, N.
Right arrow Articles by SCHYDLOWER, M.

Drug Screening

NORMAN FOST MD1, S. KENNETH SCHONBERG MD2, and MANUEL SCHYDLOWER MD3

1 Chairman, Committee on Bioethics
2 Chairman, Committee on Adolescence
3 Interim Chairman, Provisional Committee on Substance Abuse

In Reply.—

The writers raise a number of issues involving process, fact, and ethics. We can only respond to a few of the main points.

Regarding process, a major impetus for the statement was requests from private practitioners seeking the Academy's support to help them resist demands, from school districts and parents, that they screen athletes and patients surreptitiously. There was extensive involvement by private practitioners in the writing, review, and approval of the statement by three committees, the Council on Child and Adolescent health, and the Executive Board, which is comprised predominantly of private practitioners.